Non-pharmacologic strategies for the management of intestinal inflammation

Inflammatory bowel diseases, irritable bowel syndrome, and mucositis are characterized by intestinal inflammation, but vary according to their pathological mechanisms, severity, location, and etiology. Significant intestinal inflammation that occurs in these diseases induces weight loss, nutritional...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tatiani Uceli Maioli, Luísa Martins Trindade, Aline Souza, Lícia Torres, Maria Emília Rabelo Andrade, Valbert Nascimento Cardoso, Simone Vasconcelos Generoso
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Intestinal inflammation Omega-3 Probiotic Prebiotic Synbiotic FODMAP Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/e3b29659bb694ec9b7fd1c4a67214c50
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e3b29659bb694ec9b7fd1c4a67214c50
record_format	dspace
spelling	oai:doaj.org-article:e3b29659bb694ec9b7fd1c4a67214c502021-11-22T04:17:39ZNon-pharmacologic strategies for the management of intestinal inflammation0753-332210.1016/j.biopha.2021.112414https://doaj.org/article/e3b29659bb694ec9b7fd1c4a67214c502022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221012002https://doaj.org/toc/0753-3322Inflammatory bowel diseases, irritable bowel syndrome, and mucositis are characterized by intestinal inflammation, but vary according to their pathological mechanisms, severity, location, and etiology. Significant intestinal inflammation that occurs in these diseases induces weight loss, nutritional depletion, and gastrointestinal tract dysfunction. Nutritional support is important in alleviating symptoms and improving patients’ quality of life. In this review, we summarize some nutritional components used to manage intestinal disorders. These include fatty acids, probiotics, parabiotics, postbiotics, prebiotics, synbiotics, and low FODMAP (LFD) diets. These components and LFD diets have been studied and clinical trials have been designed to develop new strategies to alleviate intestinal inflammation and improve the quality of life. Clinical trials on their use in intestinal inflammation do not allow firm conclusions to be drawn mainly because of the heterogeneity of the dose used and the study design or their inconclusive results. However, in the majority of cases, the use of omega-3, probiotics, parabiotics, postbiotics, prebiotics, synbiotics, and LFD improve the health.Tatiani Uceli MaioliLuísa Martins TrindadeAline SouzaLícia TorresMaria Emília Rabelo AndradeValbert Nascimento CardosoSimone Vasconcelos GenerosoElsevierarticleIntestinal inflammationOmega-3ProbioticPrebioticSynbioticFODMAPTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112414- (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Intestinal inflammation Omega-3 Probiotic Prebiotic Synbiotic FODMAP Therapeutics. Pharmacology RM1-950
spellingShingle	Intestinal inflammation Omega-3 Probiotic Prebiotic Synbiotic FODMAP Therapeutics. Pharmacology RM1-950 Tatiani Uceli Maioli Luísa Martins Trindade Aline Souza Lícia Torres Maria Emília Rabelo Andrade Valbert Nascimento Cardoso Simone Vasconcelos Generoso Non-pharmacologic strategies for the management of intestinal inflammation
description	Inflammatory bowel diseases, irritable bowel syndrome, and mucositis are characterized by intestinal inflammation, but vary according to their pathological mechanisms, severity, location, and etiology. Significant intestinal inflammation that occurs in these diseases induces weight loss, nutritional depletion, and gastrointestinal tract dysfunction. Nutritional support is important in alleviating symptoms and improving patients’ quality of life. In this review, we summarize some nutritional components used to manage intestinal disorders. These include fatty acids, probiotics, parabiotics, postbiotics, prebiotics, synbiotics, and low FODMAP (LFD) diets. These components and LFD diets have been studied and clinical trials have been designed to develop new strategies to alleviate intestinal inflammation and improve the quality of life. Clinical trials on their use in intestinal inflammation do not allow firm conclusions to be drawn mainly because of the heterogeneity of the dose used and the study design or their inconclusive results. However, in the majority of cases, the use of omega-3, probiotics, parabiotics, postbiotics, prebiotics, synbiotics, and LFD improve the health.
format	article
author	Tatiani Uceli Maioli Luísa Martins Trindade Aline Souza Lícia Torres Maria Emília Rabelo Andrade Valbert Nascimento Cardoso Simone Vasconcelos Generoso
author_facet	Tatiani Uceli Maioli Luísa Martins Trindade Aline Souza Lícia Torres Maria Emília Rabelo Andrade Valbert Nascimento Cardoso Simone Vasconcelos Generoso
author_sort	Tatiani Uceli Maioli
title	Non-pharmacologic strategies for the management of intestinal inflammation
title_short	Non-pharmacologic strategies for the management of intestinal inflammation
title_full	Non-pharmacologic strategies for the management of intestinal inflammation
title_fullStr	Non-pharmacologic strategies for the management of intestinal inflammation
title_full_unstemmed	Non-pharmacologic strategies for the management of intestinal inflammation
title_sort	non-pharmacologic strategies for the management of intestinal inflammation
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/e3b29659bb694ec9b7fd1c4a67214c50
work_keys_str_mv	AT tatianiucelimaioli nonpharmacologicstrategiesforthemanagementofintestinalinflammation AT luisamartinstrindade nonpharmacologicstrategiesforthemanagementofintestinalinflammation AT alinesouza nonpharmacologicstrategiesforthemanagementofintestinalinflammation AT liciatorres nonpharmacologicstrategiesforthemanagementofintestinalinflammation AT mariaemiliarabeloandrade nonpharmacologicstrategiesforthemanagementofintestinalinflammation AT valbertnascimentocardoso nonpharmacologicstrategiesforthemanagementofintestinalinflammation AT simonevasconcelosgeneroso nonpharmacologicstrategiesforthemanagementofintestinalinflammation
_version_	1718418253725827072

Non-pharmacologic strategies for the management of intestinal inflammation

Ejemplares similares